As one of the world’s largest pharmaceutical and healthcare organisations, Sanofi is constantly developing and delivering new treatments for human ailments. However, as all medical scientists know, every intervention has a range of consequences for the patient – and these need to be tested and understood. So when Sanofi embarked on scoping out a new internal control department and identifying and establishing a new standard for internal controls across the whole group, the task was, as Lynette Biddulph, head of evaluations, says, “daunting”.
ComplianceSeptember 10, 2020
Sanofi Case Study: TeamMate+ Audit and Controls
Healthcare giant Sanofi adopted Wolters Kluwer’s TeamMate+ to integrate processes across a new internal control department and internal audit. It soon found that it opened up far greater assurance possibilities across the global organisation.